Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
182 hedge funds and large institutions have $2.6B invested in Medicines Co in 2013 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 66 reducing their positions, and 21 closing their positions.
52% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 21
29% more call options, than puts
Call options by funds: $11.1M | Put options by funds: $8.59M
6% more capital invested
Capital invested by funds: $2.46B → $2.6B (+$148M)
6% more funds holding
Funds holding: 172 → 182 (+10)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 66
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$32.2M |
| 2 |
BM
Bridger Management
New York
|
+$22.5M |
| 3 |
Neuberger Berman Group
New York
|
+$16.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.9M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$51.8M |
| 2 |
ZDA
Zweig-DiMenna Associates
New York
|
-$21.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$12.7M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$11.1M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$8.9M |
MDCO Hedge Fund Activity: Q4 2013 in Review
182 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2013, worth a combined $2.6B — up 6% from $2.46B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new MDCO positions and 21 closed out — a net gain of 11 holders — while 64 added to existing stakes and 66 trimmed.
The largest buyer was Frontier Capital Management, adding an estimated $32.2M. The largest seller was PointState Capital, cutting an estimated $51.8M.
- 182 institutional investors held Medicines Co (MDCO) as of Q4 2013, up from 172 in Q3 2013.
- Funds reported $2.6B of Medicines Co stock for Q4 2013, up 6% quarter-over-quarter.
- 32 funds opened new Medicines Co positions in Q4 2013 and 21 closed out, a net change of +11 holders.
- The largest Medicines Co buyer in Q4 2013 was Frontier Capital Management, an estimated $32.2M added.
- The largest Medicines Co seller in Q4 2013 was PointState Capital, an estimated $51.8M sold.
Based on aggregated 13F filings for Q4 2013.